Stay updated on Ruxolitinib in COVID Cytokine Storm Clinical Trial

Sign up to get notified when there's something new on the Ruxolitinib in COVID Cytokine Storm Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ruxolitinib in COVID Cytokine Storm Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    6 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T23:31:10.000Z thumbnail image
  6. Check
    13 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the efficacy and safety assessment of ruxolitinib in patients with COVID-19 associated cytokine storm in a Phase III clinical trial.
    Difference
    0.1%
    Check dated 2024-06-06T14:47:36.000Z thumbnail image
  7. Check
    28 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.'
    Difference
    16%
    Check dated 2024-05-22T21:35:51.000Z thumbnail image
  8. Check
    50 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:22:35.000Z thumbnail image

Stay in the know with updates to Ruxolitinib in COVID Cytokine Storm Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ruxolitinib in COVID Cytokine Storm Clinical Trial page.